OculoplasticsReviewTreatmentQ1IF 5.2
Five studies found no subjective worsening in dry eye symptoms after upper eyelid surgery.
M Reza Vagefi … Edward J Wladis
Ophthalmology · Dec 2025 · Q1 in Ophthalmology
OculoplasticsSystematic reviewQ1IF 5.2
“
The existing literature on PSIs for orbital surgery contains a heterogeneity of indications, designs, materials, and reporting.
Orbital Patient-Specific (Customized) Implants: A Report by the American Academy of Ophthalmology.
Michael K Yoon … Edward J Wladis
Ophthalmology · Aug 2025 · Q1 in Ophthalmology
More results
Eight of the 19 studies compared a PSI group with a control group (other forms of implants such as preformed, prebent sheets)-5 studies involved acute fracture repair and 3 involved a mixture of acute, delayed, or revision surgery.
More results
The remaining 11 studies did not have a comparison group, and indications included acute fracture repair (n = 2), delayed or secondary fracture repair (n = 3), or an after-tumor resection (n = 5).
Patient-specific implant material included titanium (n = 12), polyether ether ketone (PEEK) (n = 3), porous polyethylene (n = 2), and ceramic (n = 2).
OculoplasticsReviewClinical practiceQ1IF 5.2
Vision loss from filler injection usually does not improve despite treatment.
Vision-Threatening Complications of Soft Tissue Fillers: A Report by the American Academy of Ophthalmology.
Jill Foster … Edward J Wladis
Ophthalmology · Aug 2025 · Q1 in Ophthalmology
70%
Results
70%
of patients checked, vision stayed unchanged after treatment - no improvement
n = 198 cases
More results
All 19 articles were assigned a level III rating by the panel methodologist.
This assessment identified 198 cases of vision loss caused by accidental intravascular injection of filler material, hyaluronic acid gel in 164 cases (83%), autologous fat in 29 cases (15%), collagen in 3 cases, poly-L lactic acid gel in 1 case, and calcium hydroxyapatite in 1 case.
More results
The 226 injection sites, sometimes multiple locations, when described, were nose in 90 cases (40%); forehead in 56 cases (25%); glabella in 26 cases (12%); temple in 21 cases (9%) frontal in 17 cases (7%); nasolabial fold in 9 cases (4%); face in 2 cases; periocular in 2 cases; and lip, eyebrow, cheek, and upper eyelid in 1 case each.
“
Conclusion · 1 of 3
Inadvertent intravascular injection of soft tissue fillers is associated with cases of vision loss, with upper and central midface a common site of injection.
Conclusion · 2 of 3
This suggests zones of higher risk for vision loss compared with other facial areas. Hyaluronic acid gel was the most common material, although vison loss was also associated with a variety of other filler materials.
Conclusion · 3 of 3
No evidence-based protocol has been established for managing vision loss, but intra-arterial thrombolysis has had some success in recanalizing occluded arteries.